Use and costs of low-value health services by Veterans in VA and non-VA settings
Use and costs of low-value health services by Veterans in VA and non-VA settings
批准号:
10647622
负责人:
Carolyn Timberlake Thorpe
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-01 至 2023-12-31
关键词:
AddressAgeAreaCardiovascular systemCaringCategoriesClassificationCommunitiesCommunity HealthcareDataDeimplementationDiagnosticDimensionsDual EnrollmentEligibility DeterminationEnrollmentEnsureEvolutionFrequenciesGoalsHealth Care CostsHealth InsuranceHealth PersonnelHealth ServicesHealth systemHealthcareHealthcare SystemsImageInterventionInterviewKnowledgeLightLongevityMeasuresMedical centerMedicareMedicare claimMethodologyMethodsOperative Surgical ProceduresParentsPatientsPatternPerformancePoliciesPopulationPrevalencePreventivePrivatizationProceduresProviderQuality of CareReportingResearchRiskSafetyScreening for cancerServicesStatutes and LawsStructureSubgroupTestingUnited StatesVariantVeteransVeterans Health AdministrationWorkagedbeneficiarycohortcostcost estimateempowermenthealth care settingshealth economicshealth service usehigh riskimplementation effortsimprovedinnovationmultidisciplinarymultilevel analysisnoveloperationprograms
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Background: Overuse of health services whose immediate or downstream costs or harms exceed their
benefits (i.e., low-value health services) is a major driver of healthcare costs in the United States.
Comprehensive measures of low-value service use have been applied to identify low-value services with the
highest utilization and costs in non-VA populations, but less is known about which low-value services are most
frequently used and costly in Veterans managed in the Veterans Health Administration (VHA). Also, all
Veterans aged 65+ are eligible to use non-VA care via Medicare, and Veterans of all ages increasingly receive
care outside VA through VA Community Care (VACC). Past research suggests that dual use of VA and non-
VA care places Veterans at risk for overuse of health services, but information on Veterans’ use of low-value
services in non-VA settings is lacking. Significance/Impact: Our objective is to determine the extent of
utilization, costs, and determinants of Veterans' low-value service use within and outside VA. Our study will
identify the low-value services most commonly used by Veterans through VA Medical Centers (VAMCs),
VACC, and dual Medicare benefits, and those that are most costly. This study will inform policies and
interventions, including possible new quality metrics, to reduce low-value care provided to Veterans. Results
will be valuable to our VA partners (Office of Reporting, Analysis, Performance Improvement and Deployment,
and Office of Community Care) who are committed to ensuring that Veterans receive high-value services
regardless of where they receive care. It will also empower Veterans to consider value of care when choosing
between a VA vs non-VA setting. This study addresses two Veteran Care Priorities (health care value; quality/
safety of care) and the VA legislation priority to understand impact of non-VA care on value of care received by
Veterans in light of the MISSION Act. Innovation: Current VA performance metrics capture key dimensions of
access, quality, safety, and efficiency, but do not address Veterans' receipt of low-value care or quality of care
received in non-VA settings. Our project will use novel methods to quantify use and determinants of an array of
low-value services that Veterans may receive both within and outside of VA. Specific Aims: Aim 1: Quantify
utilization and costs of low-value services provided to VHA enrollees in VAMCs and VACC, and characterize
variation across VA facilities in low-value services provided in each setting. Aim 2: Quantify utilization and
costs of low-value services used by dual VHA-Medicare enrollees in VAMCs and non-VA settings through
Medicare, and characterize VA facility-level variation in low-value services provided in each setting. Aim 3:
Identify barriers and facilitators of de-implementing low-value services in each setting. Methodology: In Aim 1,
we will apply a claims-based measure of low-value care to VA utilization data and VACC data for a national
cohort of VHA enrollees. We will identify frequency of use of 26 low-value services in 6 categories: cancer
screening, diagnostic/preventive testing, preoperative testing, imaging, cardiovascular testing/procedures, and
surgery. We will apply average HERC cost estimates to calculate total costs of each service and category in
VAMCs and in VACC. We will use multilevel modeling to examine facility variation in rates of VAMC and VACC
low-value service use and extent to which Veteran and VAMC factors explain this variation. Aim 2 will involve
similar analyses involving VA utilization data and Medicare claims for dual VA-Medicare enrollees. Aim 3 will
apply latent profile analysis to facility-level estimates of low-value service categories to identify clusters of
VAMCs with similar patterns of low-value service use in VA and non-VA settings. We will conduct interviews
with VA providers who practice at VAMCs in different clusters to examine barriers and facilitators to de-
implementing low-value services for Veterans. Next Steps & Implementation: We will use results to work with
operations partners to develop performance measures, policies, and interventions to mitigate Veterans’ receipt
of low-value care in VA and non-VA settings, as VA evolves as a provider and payer of Veteran care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Health Outcomes of Discontinuing Aspirin in Older Adults with Alzheimer's Disease and Related Dementias
-
批准号:10662129
-
项目类别:
-
资助金额:$64.96万
-
财政年份:2023
-
负责人:Carolyn Timberlake Thorpe
-
依托单位:
Use and Effectiveness of Infection Prophylaxis Strategies in a National Cohort of Patients with ANCA Vasculitis
-
批准号:10196144
-
项目类别:
-
资助金额:$27.21万
-
财政年份:2021
-
负责人:Carolyn Timberlake Thorpe
-
依托单位:
Use and Effectiveness of Infection Prophylaxis Strategies in a National Cohort of Patients with ANCA Vasculitis
-
批准号:10350714
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2021
-
负责人:Carolyn Timberlake Thorpe
-
依托单位:
De-Intensifying Unnecessary Medications in VA CLC Residents Nearing End of Life
-
批准号:9904143
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Carolyn Timberlake Thorpe
-
依托单位:
De-Intensifying Unnecessary Medications in VA CLC Residents Nearing End of Life
-
批准号:9768203
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Carolyn Timberlake Thorpe
-
依托单位:
De-Intensifying Unnecessary Medications in VA CLC Residents Nearing End of Life
-
批准号:9894749
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Carolyn Timberlake Thorpe
-
依托单位:
De-Intensifying Unnecessary Medications in VA CLC Residents Nearing End of Life
-
批准号:10308424
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Carolyn Timberlake Thorpe
-
依托单位:
De-Intensifying Unnecessary Medications in VA CLC Residents Nearing End of Life
-
批准号:10186480
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Carolyn Timberlake Thorpe
-
依托单位:
Medication Oversupply and Outcomes in Patients with Diabetes
-
批准号:8141385
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2010
-
负责人:Carolyn Timberlake Thorpe
-
依托单位:
Medication Oversupply and Outcomes in Patients with Diabetes
-
批准号:8029941
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2010
-
负责人:Carolyn Timberlake Thorpe
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: